KIMS Hospitals Financial Highlights and ESG Initiatives
KIMS
HOSPITALSTM
Profit and Loss Statement
(Rupees in Millions)
Consolidated
Particulars
Q3 FY 23
Q2 FY 23
Q3 FY 22
QoQ(%)
YoY(%)
FY 22
FY 21
YoY(%)
Operating Revenue
5,622
5,641
3,936
-0.3%
42.8%
16,508
13,299
24.1%
Other Income
64
92
24
-29.9%
169.6%
203
102
99.3%
Total Revenue
5,686
5,733
3,960
-0.8%
43.6%
16,711
13,401
24.7%
EBITDA*
1,444
1,447
1,289
-0.2%
12.1%
5,218
3,672
42.1%
EBITDA (%) on operating revenue
25.7%
25.7%
32.7%
31.6%
27.6%
PBT
1,128
1,226
1,123
-8.0%
0.4%
4,569
2,790
63.7%
PBT (%) on total revenue
19.8%
21.4%
28.4%
27.3%
20.8%
PAT**
818
912
842
-10.3%
-2.8%
3,438
2,055
67.3%
PAT (%) on total revenue
14.4%
15.9%
21.3%
20.6%
15.3%
Basic EPS (Rs.)
9.5
12.1
10.1
-21.8%
-6.4%
41.9
26.9
55.9%
Diluted EPS (Rs.)
9.5
12.1
10.1
-21.8%
-6.4%
41.9
26.4
58.5%
IND AS 116
67.9
77.3
8.2
Minority share of EBITDA for 9 months stands at 12.7%
*EBITDA before IND AS 116 and other income
**PAT is exluding fair value gain on aquisition of control amounting to INR 148.3 Mn in Q2 FY23
Private & Confidential
35.4
36.6
31View entire presentation